Stock info Kamada Ltd | Filter  Basic-Info

Kamada Ltd

The past year was a good year for Kamada Ltd investors

Over the last 12 months, that were profitable period for the investors in Kamada Ltd, the stock gained around 28 percent. Kamada Ltd' stock lost the past 5 years at around 0 percent. Kamada Ltd's revenues between 2011 and 2015 were relatively stable and moved between 59,56 million dollars and 71,07 million dollars. Kamada Ltd's net incomes between 2011 and 2015 were quiet stable and moved between -14,43 million dollars and -13,21 million dollars.

The core activities of Kamada Ltd are in the biotech sector. The global biotech companies gained around 59 percent over the period 2006-2016. Over the past 5 years the sector is 70 percent higher.

The American company didn't pay out any dividends (in the past 5 years).

Kamada Ltd' balance mostly consists of equity

As per the end of 2015 the American company's balance sheet equaled 119,14 million dollars. Of the total balance sheet 38,72 million dollars (32,5 percent) was financed by debt. As per the end of 2015 Kamada Ltd's price/earnings-ratio equaled -10. So investors paid for 1 stock -10 times the earnings per share of 2015. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the American company's market capitalization equaled around 151,87 million dollars. At the end of 2015 around 35,99 million stocks were listed.

All of Kamada Ltd's annual reports are stored here. More information about Kamada Ltd can be found it's website. .